Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiqing Su

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Carbohydrate Polymers|June 17, 2015
A morpholinium ionic liquid for cellulose dissolutionDilip G Raut, Ola Sundman, Weiqing Su, et al.
The Journal of Pharmacy and Pharmacology|September 27, 2015
Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptorYiqiang Xue, Xiaorong Shui, Weiqing Su, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysisYangyi Lin, Lingpin Pang, Shian Huang, et al.
Cardiology|March 23, 2023
A Nomogram for Predicting 3-Year Mortality in Patients with Pulmonary Hypertension due to Left Heart Failure: A Retrospective Analysis of a Prospective Registry StudyYangyi Lin, Lingpin Pang, Shian Huang, et al.
Frontiers in Cardiovascular Medicine|August 19, 2022
The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort studyYangyi Lin, Lingpin Pang, Shian Huang, et al.
Thrombosis Journal|October 4, 2024
Relationship between serum uric acid levels and pulmonary embolism: an age-based stratified analysisBin Yuan, Lingyue Song, Weiqing Su, et al.
BMC Cardiovascular Disorders|February 17, 2022
Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamicsRuilin Quan, Shian Huang, Lingpin Pang, et al.
Frontiers in Cardiovascular Medicine|May 2, 2022
Tanshinone IIA Has a Potential Therapeutic Effect on Kawasaki Disease and Suppresses Megakaryocytes in Rabbits With Immune VasculitisHui Chen, Huiying Shu, Weiqing Su, et al.
Chinese Medical Journal|October 5, 2022
Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in ChinaLi Huang, Lingpin Pang, Qing Gu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Carbohydrate Polymers|June 17, 2015
A morpholinium ionic liquid for cellulose dissolutionDilip G Raut, Ola Sundman, Weiqing Su, et al.
The Journal of Pharmacy and Pharmacology|September 27, 2015
Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptorYiqiang Xue, Xiaorong Shui, Weiqing Su, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysisYangyi Lin, Lingpin Pang, Shian Huang, et al.
Cardiology|March 23, 2023
A Nomogram for Predicting 3-Year Mortality in Patients with Pulmonary Hypertension due to Left Heart Failure: A Retrospective Analysis of a Prospective Registry StudyYangyi Lin, Lingpin Pang, Shian Huang, et al.
Frontiers in Cardiovascular Medicine|August 19, 2022
The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort studyYangyi Lin, Lingpin Pang, Shian Huang, et al.
Thrombosis Journal|October 4, 2024
Relationship between serum uric acid levels and pulmonary embolism: an age-based stratified analysisBin Yuan, Lingyue Song, Weiqing Su, et al.
BMC Cardiovascular Disorders|February 17, 2022
Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamicsRuilin Quan, Shian Huang, Lingpin Pang, et al.
Frontiers in Cardiovascular Medicine|May 2, 2022
Tanshinone IIA Has a Potential Therapeutic Effect on Kawasaki Disease and Suppresses Megakaryocytes in Rabbits With Immune VasculitisHui Chen, Huiying Shu, Weiqing Su, et al.
Chinese Medical Journal|October 5, 2022
Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in ChinaLi Huang, Lingpin Pang, Qing Gu, et al.
Pageof 1